From: The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population
 | Cardiovascular mortality | All-cause mortality | |||||||
---|---|---|---|---|---|---|---|---|---|
N (%) | LAR HR (95% CI) | P value | p-int | N (%) | LAR HR (95% CI) | P value | p-int | ||
Age |  |  |  | 0.044 |  |  |  | < 0.001 | |
 <65 years | 33 (0.3%) | 0.496 (0.173, 1.425) | 0.193 |  | 255 (2.6%) | 0.686 (0.436, 1.080) | 0.103 |  | |
 ≥ 65 years | 117 (4.5%) | 0.071 (0.013, 0.395) | 0.003 |  | 617 (23.5%) | 0.164 (0.083, 0.325) | < 0.001 |  | |
Gender | Â | Â | Â | 0.487 | Â | Â | Â | 0.066 | |
 Male | 98 (1.6%) | 0.209 (0.050, 0.877) | 0.032 |  | 516 (8.6%) | 0.282 (0.160, 0.498) | < 0.001 |  | |
 Female | 52 (0.8%) | 0.382 (0.118, 1.238) | 0.109 |  | 356 (5.6%) | 0.545 (0.325, 0.912) | 0.021 |  | |
CAD | Â | Â | Â | 0.978 | Â | Â | Â | 0.636 | |
 Yes | 35 (2.6%) | 0.298 (0.055, 1.633) | 0.163 |  | 190 (14.4%) | 0.476 (0.223, 1.013) | 0.054 |  | |
 No | 115 (1.0%) | 0.306 (0.102, 0.922) | 0.035 |  | 682 (6.1%) | 0.389 (0.246, 0.615) | < 0.001 |  | |
Diabetes | Â | Â | Â | 0.124 | Â | Â | Â | 0.258 | |
 Yes | 48 (2.5%) | 0.749 (0.165, 3.412) | 0.709 |  | 312 (16.2%) | 0.529 (0.287, 0.972) | 0.040 |  | |
 No | 102 (1.0%) | 0.187 (0.059, 0.593) | 0.004 |  | 560 (5.3%) | 0.346 (0.209, 0.572) | < 0.001 |  | |
Lipid-lowering medication | Â | Â | Â | 0.843 | Â | Â | Â | 0.116 | |
 Yes | 67 (2.5%) | 0.275 (0.068, 1.117) | 0.071 |  | 316 (11.9%) | 0.602 (0.320, 1.133) | 0.116 |  | |
 No | 83 (0.8%) | 0.327 (0.097, 1.095) | 0.070 |  | 556 (5.7%) | 0.331 (0.204, 0.538) | < 0.001 |  | |
Hypertriglyceridemia | Â | Â | Â | 0.064 | Â | Â | Â | 0.355 | |
 Yes | 50 (1.6%) | 0.814 (0.185, 3.586) | 0.785 |  | 246 (8.0%) | 0.545 (0.286, 1.039) | 0.065 |  | |
 No | 100 (1.1%) | 0.143 (0.044, 0.467) | 0.001 |  | 626 (6.7%) | 0.376 (0.231, 0.611) | < 0.001 |  |